AI models can propose thousands of drug candidates in the time it takes to run a single assay. The bottleneck has moved from design to proof. Avance Biosciences’ wet-lab analytical support for AI drug discovery and development gives AI-first teams a dedicated, automated lab partner to test, measure and validate what their models predict.
Why AI Drug Discovery Still Needs the Wet Lab
AI drug discovery only creates value once a prediction survives contact with real biology. Generative models, protein language models and structure predictors can rank candidates at remarkable speed, but every ranking is a hypothesis until it is measured in an assay.
That gap is where many AI-driven programs stall. Computational teams are rarely set up to run high-quality binding, potency, expression, stability and safety assays at scale, and building a lab from scratch takes years. Standing up a full lab team just to validate a model output rarely makes sense.
What Our AI Wet Lab Services Include
Avance’s wet-lab analytical support for AI drug discovery and development pairs experienced scientists with automated workflows, so computational teams can send in candidates and get structured, analysis-ready results back.
The service draws on the analytical platforms Avance already runs every day:
- Binding and protein characterization: ELISA, MSD, capillary electrophoresis, Western blot and LC-MS/MS to confirm that designed proteins, antibodies and peptides behave as predicted.
- Cell-based and potency assays: functional readouts that show whether a candidate does what the model says it should do in living cells.
- Genomic and molecular analysis: next-generation sequencing, qPCR, ddPCR and Sanger sequencing for gene expression, editing outcomes, and construct and sequence confirmation.
- Cell profiling: flow cytometry and FluoroSpot for immunophenotyping and cytokine response.
- Custom assay development and validation: methods built around your target and your model’s questions, then qualified for repeat use.
Automation ties it together. Avance’s robotic systems, instruments and API-connected LIMS let sample tracking, results and metadata flow into a format your data science team can use directly, ready for model retraining and active-learning loops.
Who This Service Is For
This service is built for teams that are strong on computation and need a reliable experimental partner. That includes AI-native biotechs, computational biology groups inside larger pharma, and academic spinouts moving from in silico results to first lab proof.
If you are designing antibodies, proteins, peptides, small molecules, or gene and cell therapy constructs with machine learning, you can use the service to:
- Validate top-ranked candidates before committing to costly development.
- Generate high-quality training data to close the loop between model and experiment.
- Scale from a handful of tests to large, repeatable batches without hiring a lab team.
- Move toward IND-enabling work with a partner that already supports preclinical, clinical and CMC testing.
Why Avance Biosciences
Founded in 2011, Avance is a contract research and contract testing organization in Houston, Texas, with experience across hundreds of analytical projects and more than 300 pharmaceutical and biotech clients. Our labs are FDA inspected, CLIA registered and 21 CFR Part 11 compliant.
For AI-driven programs, that foundation means the same team that runs your early validation assays can carry a program through preclinical, clinical and CMC testing, so you never have to re-establish methods with a new vendor.
We already have the scientists, robotic systems, instruments, lab space and connected LIMS in place.
FAQs
They are laboratory testing services that experimentally validate and characterize candidates designed or ranked by AI and machine learning models, with results delivered in a form that supports both decision-making and model retraining.
Avance supports cell therapies, gene therapies, gene editing, antibodies, ADCs and proteins, vaccines, and small molecules.
Yes. Results are tracked in an API-connected LIMS so structured data can be delivered in formats suited to your data science workflow.
No. Avance provides the scientists, instruments, automation and quality systems, so computational teams can focus on modeling and design.
